Itgam (integrin subunit alpha M) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Itgam (integrin subunit alpha M) Rattus norvegicus
Symbol: Itgam
Name: integrin subunit alpha M
RGD ID: 2926
Description: Predicted to enable several functions, including complement component C3b binding activity; heparan sulfate proteoglycan binding activity; and heparin binding activity. Predicted to contribute to cargo receptor activity. Involved in several processes, including response to Gram-positive bacterium; response to curcumin; and response to ischemia. Located in cell surface. Used to study mesangial proliferative glomerulonephritis; neutropenia; and transient cerebral ischemia. Biomarker of brain ischemia; diabetic retinopathy; transient cerebral ischemia; and type 2 diabetes mellitus. Human ortholog(s) of this gene implicated in lupus nephritis; persistent fetal circulation syndrome; and pre-eclampsia. Orthologous to human ITGAM (integrin subunit alpha M); PARTICIPATES IN integrin mediated signaling pathway; Entamoebiasis pathway; Leishmaniasis pathway; INTERACTS WITH 1-naphthyl isothiocyanate; 17beta-estradiol; 17beta-estradiol 3-benzoate.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: Cd11b; integrin alpha M; Integrin alpha-M; integrin, alpha M
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
GRCr81192,089,496 - 192,139,947 (+)NCBIGRCr8
mRatBN7.21182,659,047 - 182,709,501 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1182,659,000 - 182,709,503 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1191,009,691 - 191,059,554 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01198,195,778 - 198,245,649 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01190,866,175 - 190,916,092 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01199,495,312 - 199,545,738 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1199,495,298 - 199,623,960 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01206,522,794 - 206,573,619 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41187,334,413 - 187,385,583 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11187,484,293 - 187,535,464 (+)NCBI
Celera1180,308,890 - 180,355,319 (+)NCBICelera
Cytogenetic Map1q37NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Disease Annotations     Click to see Annotation Detail View

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(-)-demecolcine  (ISO)
(S)-ropivacaine  (ISO)
1,1-dichloroethene  (ISO)
1-naphthyl isothiocyanate  (EXP)
17beta-estradiol  (EXP,ISO)
17beta-estradiol 3-benzoate  (EXP)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
2,5-hexanedione  (EXP,ISO)
2-acetyl-1-alkyl-sn-glycero-3-phosphocholine  (ISO)
2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid  (ISO)
3,3',5-triiodo-L-thyronine  (ISO)
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol  (ISO)
3,4-methylenedioxymethamphetamine  (ISO)
3-mercaptopropanoic acid  (ISO)
3-methyladenine  (ISO)
3-phenoxybenzoic acid  (ISO)
4-hydroxynon-2-enal  (ISO)
5-aza-2'-deoxycytidine  (ISO)
9-cis-retinoic acid  (ISO)
acetamide  (EXP)
acetylleucyl-leucyl-norleucinal  (ISO)
acrylamide  (EXP,ISO)
agathisflavone  (EXP)
all-trans-4-oxoretinol  (ISO)
all-trans-retinoic acid  (ISO)
alternariol  (ISO)
ammonium chloride  (EXP)
anthra[1,9-cd]pyrazol-6(2H)-one  (ISO)
Antimony trioxide  (ISO)
antirheumatic drug  (ISO)
apocynin  (ISO)
aristolochic acid A  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenous acid  (ISO)
asperentin  (ISO)
atorvastatin calcium  (ISO)
atrazine  (EXP)
auranofin  (ISO)
benzo[a]pyrene  (ISO)
bisphenol A  (EXP,ISO)
bupivacaine  (ISO)
C60 fullerene  (EXP)
cadmium atom  (ISO)
cadmium dichloride  (ISO)
caffeine  (ISO)
Calcimycin  (ISO)
calciol  (ISO)
calcitriol  (ISO)
carbon nanotube  (EXP,ISO)
carnosic acid  (ISO)
chlordecone  (ISO)
chloroprene  (ISO)
chloroquine  (ISO)
chlorpyrifos  (ISO)
cholesterol  (ISO)
choline  (ISO)
cisplatin  (ISO)
clonidine  (ISO)
copper atom  (EXP)
copper(0)  (EXP)
curcumin  (ISO)
cyclizine  (ISO)
cypermethrin  (ISO)
deguelin  (ISO)
dexamethasone  (ISO)
diallyl disulfide  (ISO)
diarsenic trioxide  (ISO)
dibenziodolium  (ISO)
dichlorvos  (EXP)
diclofenac  (ISO)
dimemorfan  (ISO)
dimethyl sulfoxide  (ISO)
dioxygen  (EXP,ISO)
disulfiram  (ISO)
dorsomorphin  (ISO)
endosulfan  (EXP)
entinostat  (ISO)
epalrestat  (ISO)
Erythropoietin  (ISO)
estrone  (EXP)
ethanol  (ISO)
ethyl methanesulfonate  (ISO)
ethylenediaminetetraacetic acid  (ISO)
everolimus  (ISO)
excitatory amino acid agonist  (EXP)
fenvalerate  (EXP)
flavonoids  (EXP)
fluoxetine  (ISO)
folic acid  (ISO)
formaldehyde  (ISO)
fulvestrant  (ISO)
Fulvic acid  (ISO)
gallic acid  (ISO)
gefitinib  (ISO)
genistein  (ISO)
Ginkgoic acid  (ISO)
ginsenoside Rb1  (EXP)
glutathione  (ISO)
glyburide  (EXP)
GW 4064  (ISO)
halothane  (ISO)
heparin  (ISO)
hexadecanoic acid  (ISO)
high-density lipoprotein  (ISO)
hydralazine  (ISO)
hydrogen peroxide  (ISO)
ibuprofen  (EXP)
indometacin  (EXP,ISO)
iron atom  (ISO)
iron(0)  (ISO)
isoflurane  (ISO)
isoliquiritigenin  (ISO)
isoprenaline  (ISO)
kaempferol  (ISO)
kainic acid  (ISO)
KT 5720  (ISO)
L-methionine  (ISO)
lactacystin  (ISO)
lead nitrate  (ISO)
leukotriene B4  (ISO)
lidocaine  (EXP,ISO)
lipopolysaccharide  (EXP,ISO)
lithium chloride  (ISO)
lithocholic acid  (ISO)
low-density lipoprotein  (ISO)
LY294002  (ISO)
maneb  (ISO)
manganese atom  (EXP)
manganese(0)  (EXP)
manganese(II) chloride  (EXP)
mannitol  (ISO)
mechlorethamine  (EXP)
memantine  (EXP)
methamphetamine  (ISO)
methoxychlor  (EXP)
methyl methanesulfonate  (ISO)
methyllycaconitine  (ISO)
midazolam  (ISO)
minocycline  (ISO)
ML-7  (ISO)
Morphine-3-glucuronide  (EXP)
mycophenolic acid  (ISO)
mycotoxin  (ISO)
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine  (ISO)
N-(6-acetamidohexyl)acetamide  (ISO)
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide  (ISO)
N-acetyl-L-cysteine  (ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (ISO)
N-formyl-L-methionyl-L-leucyl-L-phenylalanine  (ISO)
N-methyl-4-phenylpyridinium  (EXP,ISO)
N-tosyl-L-phenylalanyl chloromethyl ketone  (ISO)
neoechinulin A  (ISO)
nickel atom  (ISO)
notoginsenoside R1  (EXP)
ochratoxin A  (EXP)
Oleacein  (ISO)
ozone  (EXP,ISO)
paclitaxel  (EXP,ISO)
paracetamol  (ISO)
paraquat  (EXP,ISO)
paricalcitol  (ISO)
parthenolide  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
phenethyl caffeate  (ISO)
phenobarbital  (EXP)
phorbol 13-acetate 12-myristate  (EXP,ISO)
pinostrobin  (ISO)
pitavastatin  (ISO)
PJ34  (EXP)
plaunotol  (ISO)
pluronic P-123  (ISO)
Poloxamer  (ISO)
poly(I:C)  (EXP)
poly(styrene)  (ISO)
progesterone  (ISO)
pyrithiamine  (EXP)
pyrithione  (ISO)
quartz  (EXP)
quercetin  (ISO)
reparixin  (ISO)
resveratrol  (EXP,ISO)
rimonabant  (EXP)
rolipram  (ISO)
rotenone  (EXP)
rutin  (EXP)
ryanodine  (ISO)
SB 203580  (ISO)
SB 431542  (ISO)
senecionine  (ISO)
serotonin  (ISO)
sevoflurane  (EXP)
silicon dioxide  (ISO)
simvastatin  (EXP,ISO)
sirolimus  (ISO)
sodium arsenite  (ISO)
sodium fluoride  (EXP)
sodium stibogluconate  (ISO)
Soman  (EXP)
staurosporine  (ISO)
sterigmatocystin  (ISO)
streptozocin  (EXP)
succimer  (ISO)
sulfasalazine  (ISO)
sulforaphane  (ISO)
sulfoxaflor  (EXP)
T-2 toxin  (ISO)
tacrine  (EXP)
tamibarotene  (ISO)
tamoxifen  (ISO)
Tanshinone I  (ISO)
tepoxalin  (ISO)
testosterone  (EXP)
tetrachloromethane  (ISO)
tetracycline  (ISO)
theophylline  (ISO)
thioacetamide  (EXP)
titanium dioxide  (EXP)
TMC-120A  (ISO)
tributylstannane  (EXP,ISO)
trichostatin A  (ISO)
trimethyltin  (EXP,ISO)
Triptolide  (ISO)
triptonide  (ISO)
tungsten  (ISO)
tunicamycin  (ISO)
urethane  (ISO)
valproic acid  (ISO)
vinclozolin  (EXP)
vincristine  (ISO)
vitamin D  (ISO)
xestospongin C  (ISO)
Y-27632  (ISO)
zileuton  (ISO)
zinc atom  (ISO)
zinc protoporphyrin  (ISO)
zinc sulfate  (ISO)
zinc(0)  (ISO)
ziram  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View

References - curated
# Reference Title Reference Citation
1. Crosstalk Between CD11b and Piezo1 Mediates Macrophage Responses to Mechanical Cues. Atcha H, etal., Front Immunol. 2021 Sep 22;12:689397. doi: 10.3389/fimmu.2021.689397. eCollection 2021.
2. Identification of miR-210-5p in human placentae from pregnancies complicated by preeclampsia and intrauterine growth restriction, and its potential role in the pregnancy complications. Awamleh Z and Han VKM, Pregnancy Hypertens. 2020 Jan;19:159-168. doi: 10.1016/j.preghy.2020.01.002. Epub 2020 Jan 14.
3. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Barouch FC, etal., Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1153-8.
4. Perioperative platelet and monocyte activation in patients with critical limb ischemia. Burdess A, etal., J Vasc Surg. 2010 Sep;52(3):697-703. doi: 10.1016/j.jvs.2010.04.024.
5. Preventing the infiltration of leukocytes by monoclonal antibody blocks the development of progressive ischemia in rat burns. Choi M, etal., Plast Reconstr Surg. 1995 Oct;96(5):1177-85; discussion 1186-7.
6. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. Chopp M, etal., J Cereb Blood Flow Metab. 1996 Jul;16(4):578-84. doi: 10.1097/00004647-199607000-00007.
7. Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Chopp M, etal., Stroke. 1994 Apr;25(4):869-75; discussion 875-6. doi: 10.1161/01.str.25.4.869.
8. Antibodies against Mac-1 attenuate neutrophil accumulation after traumatic brain injury in rats. Clark RS, etal., J Neurotrauma. 1996 Jun;13(6):333-41. doi: 10.1089/neu.1996.13.333.
9. Inhibition of human neutrophils NEP activity, CD11b/CD18 expression and elastase release by 3,4-dihydroxyphenylethanol-elenolic acid dialdehyde, oleacein. Czerwińska ME, etal., Food Chem. 2014 Jun 15;153:1-8. doi: 10.1016/j.foodchem.2013.12.019. Epub 2013 Dec 11.
10. Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach. deFilippi C, etal., J Infect Dis. 2020 Aug 17;222(6):929-939. doi: 10.1093/infdis/jiaa196.
11. Validation of the circulating monocyte being representative of the cholesterol-loaded macrophage: biomediator activity. Devaraj S and Jialal I, Arch Pathol Lab Med. 2008 Sep;132(9):1432-5. doi: 10.5858/2008-132-1432-VOTCMB.
12. Global ischemia-induced modifications in the expression of AMPA receptors and inflammation in rat brain. Dos-Anjos S, etal., Brain Res. 2009 Sep 1;1287:20-7. doi: 10.1016/j.brainres.2009.06.065. Epub 2009 Jun 27.
13. Pentameric CRP attenuates inflammatory effects of mmLDL by inhibiting mmLDL--monocyte interactions. Eisenhardt SU, etal., Atherosclerosis. 2012 Oct;224(2):384-93. doi: 10.1016/j.atherosclerosis.2012.07.039. Epub 2012 Aug 10.
14. Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis. Gao D, etal., Free Radic Biol Med. 2012 Aug 15;53(4):796-806. doi: 10.1016/j.freeradbiomed.2012.05.026. Epub 2012 May 26.
15. The effect of midazolam on neutrophil mitogen-activated protein kinase. Ghori K, etal., Eur J Anaesthesiol. 2010 Jun;27(6):562-5. doi: 10.1097/EJA.0b013e3283328442.
16. The effect of clonidine, an alpha-2 adrenergic receptor agonist, on inflammatory response and postischemic endothelium function during early reperfusion in healthy volunteers. Gourdin M, etal., J Cardiovasc Pharmacol. 2012 Dec;60(6):553-60. doi: 10.1097/FJC.0b013e31827303fa.
17. Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Hirahashi J, etal., Circulation. 2009 Sep 29;120(13):1255-65. Epub 2009 Sep 14.
18. Fasting glucose level modulates cell surface expression of CD11b and CD66b in granulocytes and monocytes of patients with type 2 diabetes. Horvath P, etal., J Investig Med. 2013 Aug;61(6):972-7. doi: 10.2310/JIM.0b013e3182961517.
19. Integrins: bidirectional, allosteric signaling machines. Hynes RO Cell 2002 Sep 20;110(6):673-87.
20. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood. Izzi B, etal., Thromb Haemost. 2007 Dec;98(6):1276-84.
21. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Jaeschke H, etal., Hepatology. 1993 May;17(5):915-23.
22. [Effect of curcumin on expressions of CD11b and CD19 in peripheral blood of heat stroke rats in a simulation dry-heat environment]. Jiang J, etal., Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Feb;31(2):221-224. doi: 10.3760/cma.j.issn.2095-4352.2019.02.019.
23. Increased BBB Permeability Enhances Activation of Microglia and Exacerbates Loss of Dendritic Spines After Transient Global Cerebral Ischemia. Ju F, etal., Front Cell Neurosci. 2018 Aug 3;12:236. doi: 10.3389/fncel.2018.00236. eCollection 2018.
24. Mac-1 (CD11b/CD18) and intercellular adhesion molecule-1 in ischemia-reperfusion injury of rat liver. Kobayashi A, etal., Am J Physiol Gastrointest Liver Physiol. 2001 Aug;281(2):G577-85. doi: 10.1152/ajpgi.2001.281.2.G577.
25. Translocator protein localises to CD11b+ macrophages in atherosclerosis. Kopecky C, etal., Atherosclerosis. 2019 May;284:153-159. doi: 10.1016/j.atherosclerosis.2019.03.011. Epub 2019 Mar 18.
26. Persistent behavioral impairments and neuroinflammation following global ischemia in the rat. Langdon KD, etal., Eur J Neurosci. 2008 Dec;28(11):2310-8. doi: 10.1111/j.1460-9568.2008.06513.x. Epub 2008 Nov 3.
27. Store-operated calcium channel inhibition attenuates neutrophil function and postshock acute lung injury. Lee C, etal., J Trauma. 2005 Jul;59(1):56-63; discussion 63. doi: 10.1097/01.ta.0000171456.54921.fe.
28. The pattern of inflammation in rat sepsis due to enterotoxin-producing Staphylococcus aureus: a comparison with ischemia-reperfusion injury. Lin RY, etal., J Med. 1996;27(5-6):303-17.
29. Organ-specific innate immune responses in a mouse model of invasive candidiasis. Lionakis MS, etal., J Innate Immun. 2011;3(2):180-99. doi: 10.1159/000321157. Epub 2010 Nov 9.
30. Lower prevalence of circulating invariant natural killer T (iNKT) cells in patients with acute myocardial infarction undergoing primary coronary stenting. Liu LL, etal., Int Immunopharmacol. 2011 Apr;11(4):480-4. doi: 10.1016/j.intimp.2010.12.019. Epub 2011 Jan 14.
31. Signature of subclinical femoral artery atherosclerosis in peripheral blood mononuclear cells. Llorente-Cortés V, etal., Eur J Clin Invest. 2014 Jun;44(6):539-48. doi: 10.1111/eci.12267.
32. Dysfunction of complement receptors CR3 (CD11b/18) and CR4 (CD11c/18) in pre-eclampsia: a genetic and functional study. Lokki AI, etal., BJOG. 2021 Jul;128(8):1282-1291. doi: 10.1111/1471-0528.16660. Epub 2021 Mar 14.
33. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease. Macey M, etal., Rheumatology (Oxford). 2011 Oct;50(10):1849-59. doi: 10.1093/rheumatology/ker177. Epub 2011 Jun 29.
34. Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Maiguel D, etal., Sci Signal. 2011 Sep 6;4(189):ra57. doi: 10.1126/scisignal.2001811.
35. A Genetic Model of Constitutively Active Integrin CD11b/CD18. Martinez L, etal., J Immunol. 2020 Nov 1;205(9):2545-2553. doi: 10.4049/jimmunol.1901402. Epub 2020 Sep 16.
36. Down regulation of CD11b and CD18 expression in children with hypercholesterolemia: a preliminary report. Martino F, etal., Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):105-9. doi: 10.1016/j.numecd.2008.05.001. Epub 2008 Aug 3.
37. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy. Mastej K and Adamiec R, Acta Diabetol. 2008 Sep;45(3):183-90. doi: 10.1007/s00592-008-0040-0. Epub 2008 May 22.
38. Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation. Mauler M, etal., Circulation. 2019 Feb 12;139(7):918-931. doi: 10.1161/CIRCULATIONAHA.118.033942.
39. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. Mazor R, etal., Atherosclerosis. 2008 Apr;197(2):937-43. doi: 10.1016/j.atherosclerosis.2007.08.014. Epub 2007 Sep 17.
40. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
41. Roles of beta 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury. Mulligan MS, etal., J Immunol. 1992 Mar 15;148(6):1847-57.
42. Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina. Murasaki S, etal., Heart Vessels. 2007 Nov;22(6):376-82. doi: 10.1007/s00380-007-0999-4. Epub 2007 Nov 26.
43. High-density lipoprotein reduces the human monocyte inflammatory response. Murphy AJ, etal., Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2071-7. doi: 10.1161/ATVBAHA.108.168690. Epub 2008 Jul 10.
44. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
45. Reconstituted High-Density Lipoprotein Attenuates Cholesterol Crystal-Induced Inflammatory Responses by Reducing Complement Activation. Niyonzima N, etal., J Immunol. 2015 Jul 1;195(1):257-64. doi: 10.4049/jimmunol.1403044. Epub 2015 May 29.
46. Neutrophil and monocyte toll-like receptor 4, CD11b and reactive oxygen intermediates, and neuroimaging outcomes in preterm infants. O'Hare FM, etal., Pediatr Res. 2015 Jul;78(1):82-90. doi: 10.1038/pr.2015.66. Epub 2015 Mar 31.
47. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
48. Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation. Pfluecke C, etal., Clin Res Cardiol. 2016 Apr;105(4):314-22. doi: 10.1007/s00392-015-0922-4. Epub 2015 Sep 28.
49. Atrial fibrillation is associated with high levels of monocyte-platelet-aggregates and increased CD11b expression in patients with aortic stenosis. Pfluecke C, etal., Thromb Haemost. 2016 May 2;115(5):993-1000. doi: 10.1160/TH15-06-0477. Epub 2016 Jan 14.
50. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
51. GOA pipeline RGD automated data pipeline
52. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
53. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
54. Exaggerated neutrophil-mediated reperfusion injury after ischemic stroke in a rodent model of type 2 diabetes. Ritter L, etal., Microcirculation. 2011 Oct;18(7):552-61. doi: 10.1111/j.1549-8719.2011.00115.x.
55. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Rostron AJ, etal., Transplantation. 2008 Feb 27;85(4):597-606. doi: 10.1097/TP.0b013e31816398dd.
56. Solulin reduces infarct volume and regulates gene-expression in transient middle cerebral artery occlusion in rats. Ryang YM, etal., BMC Neurosci. 2011 Nov 14;12:113. doi: 10.1186/1471-2202-12-113.
57. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Sanchez E, etal., Ann Rheum Dis. 2011 Jun 30.
58. Modulatory effect of 17β-estradiol on myeloid cell infiltration into the male rat brain after ischemic stroke. Scheld M, etal., J Steroid Biochem Mol Biol. 2020 Sep;202:105667. doi: 10.1016/j.jsbmb.2020.105667. Epub 2020 May 11.
59. Toll-like receptor 2 and 4 stimulation elicits an enhanced inflammatory response in human obese patients with atherosclerosis. Scholtes VP, etal., Clin Sci (Lond). 2011 Sep;121(5):205-14. doi: 10.1042/CS20100601.
60. Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs. Seekamp A, etal., Am J Pathol. 1993 Aug;143(2):464-72.
61. Is Iba-1 protein expression a sensitive marker for microglia activation in experimental diabetic retinopathy? Shi FJ, etal., Int J Ophthalmol. 2021 Feb 18;14(2):200-208. doi: 10.18240/ijo.2021.02.04. eCollection 2021.
62. Ischemic limb preconditioning downregulates systemic inflammatory activation. Szabó A, etal., J Orthop Res. 2009 Jul;27(7):897-902. doi: 10.1002/jor.20829.
63. The integrins. Takada Y, etal., Genome Biol. 2007;8(5):215.
64. Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies. Tamatani T, etal., Eur J Immunol. 1991 Mar;21(3):627-33.
65. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Tanga FY, etal., Neurochem Int 2004 Jul-Aug;45(2-3):397-407.
66. Reduction of atrial fibrillation burden by pulmonary vein isolation leads to a decrease of CD11b expression on inflammatory cells. Tarnowski D, etal., Europace. 2018 Mar 1;20(3):459-465. doi: 10.1093/europace/euw383.
67. Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats. Tian DS, etal., J Neurochem. 2009 Jun;109(6):1658-67. doi: 10.1111/j.1471-4159.2009.06077.x. Epub 2009 Mar 30.
68. δ-Opioid receptor activation rescues the functional TrkB receptor and protects the brain from ischemia-reperfusion injury in the rat. Tian X, etal., PLoS One. 2013 Jul 2;8(7):e69252. doi: 10.1371/journal.pone.0069252. Print 2013.
69. Neutrophil-derived reactive oxygen species can modulate neutrophil adhesion to endothelial cells in preeclampsia. Tsukimori K, etal., Am J Hypertens. 2008 May;21(5):587-91. doi: 10.1038/ajh.2007.87. Epub 2008 Mar 6.
70. RNA-seq based transcriptome analysis of the protective effect of compound longmaining decoction on acute myocardial infarction. Wang C, etal., J Pharm Biomed Anal. 2018 Sep 5;158:339-345. doi: 10.1016/j.jpba.2018.06.016. Epub 2018 Jun 18.
71. Activated microglia provide a neuroprotective role by balancing glial cell-line derived neurotrophic factor and tumor necrosis factor-α secretion after subacute cerebral ischemia. Wang J, etal., Int J Mol Med. 2013 Jan;31(1):172-8. doi: 10.3892/ijmm.2012.1179. Epub 2012 Nov 13.
72. Frequent mutation of hypoxia-related genes in persistent pulmonary hypertension of the newborn. Wang M, etal., Respir Res. 2020 Feb 13;21(1):53. doi: 10.1186/s12931-020-1314-5.
73. Inhibition of microglial activation contributes to propofol-induced protection against post-cardiac arrest brain injury in rats. Wang W, etal., J Neurochem. 2015 Sep;134(5):892-903. doi: 10.1111/jnc.13179. Epub 2015 Jun 11.
74. Protective Effects of Modeled Superoxide Dismutase Coordination Compound (MSODa) Against Ischemia/Reperfusion Injury in Rat Skeletal Muscle. Wang XT, etal., Cell Physiol Biochem. 2015;37(2):465-76. doi: 10.1159/000430369. Epub 2015 Aug 28.
75. Proteomic analysis of foot ulcer tissue reveals novel potential therapeutic targets of wound healing in diabetic foot ulcers. Wang Y, etal., Comput Biol Med. 2023 Jun;159:106858. doi: 10.1016/j.compbiomed.2023.106858. Epub 2023 Apr 13.
76. Harmful neutrophil subsets in patients with ischemic stroke: Association with disease severity. Weisenburger-Lile D, etal., Neurol Neuroimmunol Neuroinflamm. 2019 May 15;6(4):e571. doi: 10.1212/NXI.0000000000000571. eCollection 2019 Jul.
77. Distinctive roles of neutrophils and monocytes in anti-thy-1 nephritis. Westerhuis R, etal., Am J Pathol. 2000 Jan;156(1):303-10. doi: 10.1016/S0002-9440(10)64731-1.
78. Sustained monocyte activation in clinical remission of systemic vasculitis. Wikman A, etal., Inflammation. 2008 Dec;31(6):384-90. doi: 10.1007/s10753-008-9089-8.
79. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy. Xie H, etal., Diabetologia. 2021 Jan;64(1):211-225. doi: 10.1007/s00125-020-05299-x. Epub 2020 Oct 26.
80. Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel. Yong AS, etal., Blood. 2011 Jan 6;117(1):11-20. doi: 10.1182/blood-2010-04-278812. Epub 2010 Sep 27.
81. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Zhang L, etal., Stroke. 2003 Jul;34(7):1790-5. doi: 10.1161/01.STR.0000077016.55891.2E. Epub 2003 Jun 12.
82. Postischemic treatment (2-4 h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2 h) focal cerebral ischemia in the rat. Zhang ZG, etal., Brain Res. 1995 Nov 6;698(1-2):79-85. doi: 10.1016/0006-8993(95)00830-j.
83. Deficiency of ITGAM Attenuates Experimental Abdominal Aortic Aneurysm in Mice. Zhou M, etal., J Am Heart Assoc. 2021 Apr 6;10(7):e019900. doi: 10.1161/JAHA.120.019900. Epub 2021 Mar 20.
Additional References at PubMed
PMID:8043862   PMID:8552190   PMID:8557754   PMID:8562500   PMID:8769481   PMID:8788039   PMID:8986723   PMID:9324354   PMID:9862668   PMID:10528208   PMID:10848813   PMID:12163569  
PMID:12496435   PMID:12529407   PMID:14609575   PMID:15072240   PMID:15138196   PMID:15210787   PMID:15457581   PMID:15795238   PMID:15845452   PMID:16093349   PMID:16680014   PMID:16937496  
PMID:16973387   PMID:18685038   PMID:18981141   PMID:19015308   PMID:19234460   PMID:19342649   PMID:19575970   PMID:19723499   PMID:20199584   PMID:20228271   PMID:20578039   PMID:20660734  
PMID:21193407   PMID:22099750   PMID:22438044   PMID:22632727   PMID:23154389   PMID:23376485   PMID:23533145   PMID:23550035   PMID:23981064   PMID:24029230   PMID:24913911   PMID:25645918  
PMID:25667449   PMID:28807980  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
GRCr81192,089,496 - 192,139,947 (+)NCBIGRCr8
mRatBN7.21182,659,047 - 182,709,501 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1182,659,000 - 182,709,503 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1191,009,691 - 191,059,554 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01198,195,778 - 198,245,649 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01190,866,175 - 190,916,092 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01199,495,312 - 199,545,738 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1199,495,298 - 199,623,960 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01206,522,794 - 206,573,619 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41187,334,413 - 187,385,583 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11187,484,293 - 187,535,464 (+)NCBI
Celera1180,308,890 - 180,355,319 (+)NCBICelera
Cytogenetic Map1q37NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh381631,259,975 - 31,332,877 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1631,259,967 - 31,332,892 (+)EnsemblGRCh38hg38GRCh38
GRCh371631,271,296 - 31,344,198 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361631,178,789 - 31,251,714 (+)NCBINCBI36Build 36hg18NCBI36
Build 341631,178,811 - 31,251,691NCBI
Celera1628,953,869 - 29,026,766 (-)NCBICelera
Cytogenetic Map16p11.2NCBI
HuRef1628,832,071 - 28,904,704 (+)NCBIHuRef
CHM1_11632,589,199 - 32,661,884 (+)NCBICHM1_1
T2T-CHM13v2.01631,647,380 - 31,720,298 (+)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm397127,661,812 - 127,717,663 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl7127,661,812 - 127,717,663 (+)EnsemblGRCm39 Ensembl
GRCm387128,062,640 - 128,118,491 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl7128,062,640 - 128,118,491 (+)EnsemblGRCm38mm10GRCm38
MGSCv377135,206,154 - 135,262,005 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv367127,853,854 - 127,908,772 (+)NCBIMGSCv36mm8
Celera7127,897,978 - 127,954,099 (+)NCBICelera
Cytogenetic Map7F3NCBI
cM Map769.93NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_0049554938,116,834 - 8,260,759 (+)EnsemblChiLan1.0
ChiLan1.0NW_0049554938,116,886 - 8,160,806 (+)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan1-v21834,467,770 - 34,540,427 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11639,269,199 - 39,341,886 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01623,634,476 - 23,707,147 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11631,630,983 - 31,702,406 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1631,630,146 - 31,702,406 (+)Ensemblpanpan1.1panPan2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.1616,944,062 - 16,996,525 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl616,808,971 - 16,996,286 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha618,516,000 - 18,571,559 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0617,068,771 - 17,127,224 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl617,069,907 - 17,127,159 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1616,871,848 - 16,927,654 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0616,791,010 - 16,846,822 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0617,102,490 - 17,158,038 (-)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_024409344125,528,028 - 125,576,877 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365438,461,307 - 8,508,524 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_0049365438,460,526 - 8,508,524 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.1527,957,162 - 28,042,697 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl527,957,324 - 28,042,691 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_0236660681,400,356 - 1,493,976 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla_female_1.0 EnsemblNW_00462478214,318,499 - 14,367,922 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_00462478214,316,505 - 14,367,841 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in Itgam
354 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:30
Count of miRNA genes:28
Interacting mature miRNAs:29
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
10059597Bp377Blood pressure QTL 3773.420.025arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)132737458199368955Rat
634314Niddm44Non-insulin dependent diabetes mellitus QTL 44blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)149393289199050459Rat
1578780Cm52Cardiac mass QTL 523.30.0001heart mass (VT:0007028)heart wet weight (CMO:0000069)181591954219808434Rat
1331749Hrtrt11Heart rate QTL 112.973heart pumping trait (VT:2000009)heart rate (CMO:0000002)194494440198211706Rat
70209Niddm23Non-insulin dependent diabetes mellitus QTL 232.82blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)194494440198324465Rat
731168Bp154Blood pressure QTL 1543.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)194642644214537671Rat
8655649Arrd1Age-related retinal degeneration QTL 14.89retinal layer morphology trait (VT:0003727)percentage of study population developing retinopathy during a period of time (CMO:0002453)1100357752183970443Rat
1354591Cm36Cardiac mass QTL 364.1heart left ventricle mass (VT:0007031)calculated heart weight (CMO:0000073)1102813953201278233Rat
1354615Cm32Cardiac mass QTL 325.2heart left ventricle mass (VT:0007031)heart left ventricle wet weight (CMO:0000071)1102813953201278233Rat
1354606Bp246Blood pressure QTL 2463.6arterial blood pressure trait (VT:2000000)pulse pressure (CMO:0000292)1102813953218753816Rat
1300158Bp173Blood pressure QTL 1733.48arterial blood pressure trait (VT:2000000)blood pressure time series experimental set point of the baroreceptor response (CMO:0002593)1115540693185145286Rat
7794788Mcs32Mammary carcinoma susceptibility QTL 322.61mammary gland integrity trait (VT:0010552)mammary tumor incidence/prevalence measurement (CMO:0000946)1115540693238914717Rat
7421630Bp362Blood pressure QTL 3620.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1118608292241799120Rat
631205Bp196Blood pressure QTL 19640.0001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1118944897199050459Rat
631549Bp89Blood pressure QTL 895.7arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1123350581201284552Rat
1598853Memor3Memory QTL 34.5exploratory behavior trait (VT:0010471)total horizontal distance resulting from voluntary locomotion in an experimental apparatus (CMO:0001443)1143506580212458660Rat
61348Bp30Blood pressure QTL 302.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1144017057197814409Rat
70160Bw18Body weight QTL 185.7body mass (VT:0001259)body weight (CMO:0000012)1144267353196383668Rat
737828Hcas3Hepatocarcinoma susceptibility QTL 34.9liver integrity trait (VT:0010547)liver tumorous lesion volume to total liver volume ratio (CMO:0001082)1144267353222987745Rat
2302378Insul11Insulin level QTL 113.25blood insulin amount (VT:0001560)serum insulin level (CMO:0000358)1144267353251128347Rat
7771612Cm80Cardiac mass QTL 808.4heart left ventricle mass (VT:0007031)heart left ventricle weight (CMO:0000776)1149448574221264292Rat
724531Uae5Urinary albumin excretion QTL 54urine albumin amount (VT:0002871)urine albumin level (CMO:0000130)1150700142252085212Rat
1578759Uae30Urinary albumin excretion QTL 303.30.003urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1150700247252085048Rat
1578778Pur4Proteinuria QTL 43.30.003urine total protein amount (VT:0000032)urine total protein excretion rate (CMO:0000756)1150700247252085048Rat
1354602Bw35Body weight QTL 3512.2body mass (VT:0001259)body weight (CMO:0000012)1151162512201278233Rat
1354620Kidm19Kidney mass QTL 194kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1151162512201278233Rat
1354634Kidm12Kidney mass QTL 123.9kidney mass (VT:0002707)right kidney wet weight (CMO:0000082)1151162512201278233Rat
1354636Lmblg1Limb length QTL 16.4tibia length (VT:0004357)tibia length (CMO:0000450)1151162512201278233Rat
1354610Bw34Body weight QTL 344.1body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1354646Kidm18Kidney mass QTL 185.7kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1151162512256448636Rat
1354661Bw33Body weight QTL 335.2body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1358886Bp260Blood pressure QTL 2603.67arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1151162766225824951Rat
61343Bp28Blood pressure QTL 28arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1151646613196646613Rat
1549837Hcar15Hepatocarcinoma resistance QTL 150.05liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1153136852260522016Rat
2303622Vencon6Ventilatory control QTL 60.001respiration trait (VT:0001943)respiration rate (CMO:0000289)1154561505199561505Rat
4889428Stresp24Stress response QTL 240.05heart pumping trait (VT:2000009)absolute change in electrocardiographic low frequency R-R spectral component to high frequency R-R spectral component ratio (CMO:0002162)1155866514200866514Rat
1354618Kidm15Kidney mass QTL 155kidney mass (VT:0002707)left kidney wet weight (CMO:0000083)1156677124201278233Rat
2312420Pur17Proteinuria QTL 177.10.0001urine protein amount (VT:0005160)urine total protein excretion rate (CMO:0000756)1156677124218753816Rat
1354580Scort1Serum corticosterone level QTL 13.4blood corticosterone amount (VT:0005345)blood corticosterone level (CMO:0001172)1156677124256448636Rat
61347Bp197Blood pressure QTL 1974.2arterial blood pressure trait (VT:2000000)blood pressure measurement (CMO:0000003)1158633083203633083Rat
2292222Bp307Blood pressure QTL 3073.060.0014arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164310393213533942Rat
2292220Bp306Blood pressure QTL 3063.470.00087arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164310393243914901Rat
619613Bp77Blood pressure QTL 770.01arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164747424209747424Rat
619613Bp77Blood pressure QTL 770.01arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)1164747424209747424Rat
2312558Glom17Glomerulus QTL 173.90.001kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)1166532971191278129Rat
1354653Despr9Despair related QTL 90.00019locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)1167909849212909849Rat
619614Bp78Blood pressure QTL 780.001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1169112897197261052Rat
619614Bp78Blood pressure QTL 780.001arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)1169112897197261052Rat
61341Bp26Blood pressure QTL 26arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1169537671214537671Rat
724562Rends1Renal damage susceptibility QTL 10.05kidney glomerulus integrity trait (VT:0010546)index of glomerular damage (CMO:0001135)1169537671214537671Rat
1358294Bw37Body weight QTL 3750.000011body mass (VT:0001259)body weight (CMO:0000012)1171310381216310381Rat
2293689Bss47Bone structure and strength QTL 477.250.0001lumbar vertebra size trait (VT:0010518)lumbar vertebra trabecular cross-sectional area (CMO:0001692)1171629477216629477Rat
2293693Bss22Bone structure and strength QTL 2233.520.0001femur morphology trait (VT:0000559)femur cross-sectional area (CMO:0001661)1171629477216629477Rat
2300161Bmd43Bone mineral density QTL 438.40.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)1171629477216629477Rat
2300174Bmd42Bone mineral density QTL 428.40.0001lumbar vertebra mineral mass (VT:0010511)bone mineral density (CMO:0001226)1171629477216629477Rat
2300187Bmd41Bone mineral density QTL 418.90.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)1171629477216629477Rat
2293654Bss30Bone structure and strength QTL 3032.650.0001femur strength trait (VT:0010010)femur midshaft polar moment of inertia (CMO:0001669)1171629477216629477Rat
2293673Bss27Bone structure and strength QTL 2718.630.0001femur morphology trait (VT:0000559)femur midshaft cortical cross-sectional area (CMO:0001663)1171629477216629477Rat
2293677Bss41Bone structure and strength QTL 419.380.0001lumbar vertebra size trait (VT:0010518)lumbar vertebra cross-sectional area (CMO:0001689)1171629477216629477Rat
1549830Bss1Bone structure and strength QTL 14.8femur strength trait (VT:0010010)femur ultimate force (CMO:0001675)1172609619217609619Rat
631214Bw61Body weight QTL613.40.0001intramuscular adipose amount (VT:0010044)intramuscular fat area (CMO:0001162)1173108781218108781Rat
631670Iddm10Insulin dependent diabetes mellitus QTL 101.9blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)1174133260196383668Rat
70163Bw20Body weight QTL 205.1body mass (VT:0001259)body weight (CMO:0000012)1174133260219133260Rat
738032Hcas5Hepatocarcinoma susceptibility QTL 53.12liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1176426412257976495Rat
1600380Niddm70Non-insulin dependent diabetes mellitus QTL 703.10.0008blood insulin amount (VT:0001560)plasma insulin level (CMO:0000342)1176550523221550523Rat
10059600Bp378Blood pressure QTL 3783.080.05arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1176869060221869060Rat
1354624Cm35Cardiac mass QTL355.7heart left ventricle mass (VT:0007031)calculated heart weight (CMO:0000073)1177227632256448636Rat
1354652Kidm20Kidney mass QTL 204.3kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1177227632256448636Rat
1558658Bw59Body weight QTL 593.50.0003body mass (VT:0001259)body weight (CMO:0000012)1178784622223784622Rat
2325725Eae31Experimental allergic encephalomyelitis QTL 31nervous system integrity trait (VT:0010566)experimental autoimmune encephalomyelitis severity score (CMO:0001419)1178810256188377506Rat
634321Hc1Hypercalciuria QTL 12.91urine calcium amount (VT:0002985)urine calcium excretion rate (CMO:0000763)1178810256240830002Rat
1578763Kidm29Kidney mass QTL 293.30.0001kidney mass (VT:0002707)both kidneys wet weight (CMO:0000085)1179567751260522016Rat
1302787Stl25Serum triglyceride level QTL 252.70.0073blood triglyceride amount (VT:0002644)plasma triglyceride level (CMO:0000548)1180359209210702199Rat
6903303Scl34Serum cholesterol QTL 342.50.0033blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)1180359209218108781Rat
737977Bp160Blood pressure QTL 1600.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1181133855226133855Rat
61378Bp43Blood pressure QTL 4322.6arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1181746937196383668Rat
724559Pancm1Pancreatic morphology QTL 17.1islet of Langerhans morphology trait (VT:0005215)pancreatic islet damage composite score (CMO:0001156)1181759564214537555Rat
2293083Iddm25Insulin dependent diabetes mellitus QTL 254.18blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1181829673224569684Rat
634312Bp143Blood pressure QTL 14330.0002arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1182623426219932796Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21182,657,959 - 182,658,086 (+)MAPPERmRatBN7.2
Rnor_6.01199,494,211 - 199,494,337NCBIRnor6.0
Rnor_5.01206,521,673 - 206,521,799UniSTSRnor5.0
RGSC_v3.41187,333,197 - 187,333,323UniSTSRGSC3.4
Celera1180,307,674 - 180,307,800UniSTS
Cytogenetic Map1q36UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21182,657,961 - 182,658,182 (+)MAPPERmRatBN7.2
Rnor_6.01199,494,213 - 199,494,433NCBIRnor6.0
Rnor_5.01206,521,675 - 206,521,895UniSTSRnor5.0
RGSC_v3.41187,333,198 - 187,333,419RGDRGSC3.4
RGSC_v3.41187,333,199 - 187,333,419UniSTSRGSC3.4
RGSC_v3.11187,483,080 - 187,483,300RGD
Celera1180,307,676 - 180,307,896UniSTS
RH 2.0 Map1974.9RGD
Cytogenetic Map1q36UniSTS


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
Medium 1 12 2 3
Low 3 27 48 33 7 33 8 11 62 28 28 8 8
Below cutoff 10 8 8 8 10 7 11


RefSeq Acc Id: ENSRNOT00000026748   ⟹   ENSRNOP00000026748
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1182,660,679 - 182,709,503 (+)Ensembl
Rnor_6.0 Ensembl1199,495,427 - 199,545,292 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000085336   ⟹   ENSRNOP00000071107
Rat AssemblyChrPosition (strand)Source
Rnor_6.0 Ensembl1199,596,024 - 199,623,670 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000086003   ⟹   ENSRNOP00000073093
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1182,659,000 - 182,709,503 (+)Ensembl
Rnor_6.0 Ensembl1199,495,298 - 199,623,960 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000093862   ⟹   ENSRNOP00000088977
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1182,659,000 - 182,709,503 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000111931   ⟹   ENSRNOP00000082821
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1182,660,679 - 182,709,503 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000117515   ⟹   ENSRNOP00000077846
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1182,661,167 - 182,709,503 (+)Ensembl
RefSeq Acc Id: NM_012711   ⟹   NP_036843
RefSeq Status: VALIDATED
Rat AssemblyChrPosition (strand)Source
GRCr81192,089,592 - 192,139,943 (+)NCBI
mRatBN7.21182,659,144 - 182,709,501 (+)NCBI
Rnor_6.01199,495,427 - 199,545,292 (+)NCBI
Rnor_5.01206,522,794 - 206,573,619 (+)NCBI
RGSC_v3.41187,334,413 - 187,385,583 (+)RGD
Celera1180,308,890 - 180,355,319 (+)RGD
RefSeq Acc Id: XM_006230214   ⟹   XP_006230276
Rat AssemblyChrPosition (strand)Source
GRCr81192,089,496 - 192,139,947 (+)NCBI
mRatBN7.21182,659,047 - 182,709,495 (+)NCBI
Rnor_6.01199,495,312 - 199,545,738 (+)NCBI
Rnor_5.01206,522,794 - 206,573,619 (+)NCBI
RefSeq Acc Id: NP_036843   ⟸   NM_012711
- Peptide Label: precursor
- UniProtKB: A0A0G2K4L8 (UniProtKB/TrEMBL),   A6I9Y2 (UniProtKB/TrEMBL),   G3V8L7 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006230276   ⟸   XM_006230214
- Peptide Label: isoform X1
- UniProtKB: G3V8L7 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000026748   ⟸   ENSRNOT00000026748
RefSeq Acc Id: ENSRNOP00000071107   ⟸   ENSRNOT00000085336
RefSeq Acc Id: ENSRNOP00000073093   ⟸   ENSRNOT00000086003
RefSeq Acc Id: ENSRNOP00000077846   ⟸   ENSRNOT00000117515
RefSeq Acc Id: ENSRNOP00000082821   ⟸   ENSRNOT00000111931
RefSeq Acc Id: ENSRNOP00000088977   ⟸   ENSRNOT00000093862
Protein Domains


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

RGD ID:13690468
Promoter ID:EPDNEW_R976
Type:initiation region
Description:integrin subunit alpha D
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database,
Experiment Methods:Single-end sequencing.
Rat AssemblyChrPosition (strand)Source
Rnor_6.01199,495,350 - 199,495,410EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2926 AgrOrtholog
BioCyc Gene G2FUF-57313 BioCyc
Ensembl Genes ENSRNOG00000019728 Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000026748.5 UniProtKB/TrEMBL
  ENSRNOT00000086003.2 UniProtKB/TrEMBL
  ENSRNOT00000093862.1 UniProtKB/TrEMBL
  ENSRNOT00000111931.1 UniProtKB/TrEMBL
  ENSRNOT00000117515.1 UniProtKB/TrEMBL
  Bicelle-embedded integrin alpha(iib) transmembrane segment UniProtKB/TrEMBL
  Integrin domains. Chain A, domain 2 UniProtKB/TrEMBL
  ntegrin, alpha v. Chain A, domain 3 UniProtKB/TrEMBL
  ntegrin, alpha v. Chain A, domain 4 UniProtKB/TrEMBL
InterPro FG-GAP UniProtKB/TrEMBL
  Int_alpha_beta-p UniProtKB/TrEMBL
  Integrin_alpha UniProtKB/TrEMBL
  Integrin_alpha-2 UniProtKB/TrEMBL
  Integrin_alpha_C_CS UniProtKB/TrEMBL
  Integrin_alpha_Ig-like_2 UniProtKB/TrEMBL
  Integrin_alpha_N UniProtKB/TrEMBL
  Integrin_dom UniProtKB/TrEMBL
  ITGAX-like_Ig_3 UniProtKB/TrEMBL
  vWFA_dom_sf UniProtKB/TrEMBL
KEGG Report rno:25021 UniProtKB/TrEMBL
  Integrin_A_Ig_2 UniProtKB/TrEMBL
  Integrin_alpha UniProtKB/TrEMBL
  Integrin_alpha2 UniProtKB/TrEMBL
  ITGAX-like_Ig_3 UniProtKB/TrEMBL
PhenoGen Itgam PhenoGen
RatGTEx ENSRNOG00000019728 RatGTEx
SMART Int_alpha UniProtKB/TrEMBL
Superfamily-SCOP SSF53300 UniProtKB/TrEMBL
  SSF69179 UniProtKB/TrEMBL
  SSF69318 UniProtKB/TrEMBL
  A0A8I6A686_RAT UniProtKB/TrEMBL

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-05-11 Itgam  integrin subunit alpha M  Itgam  integrin, alpha M  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2009-12-15 Itgam  integrin, alpha M  Itgam  integrin alpha M  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2002-06-10 Itgam  Integrin alpha-M      Symbol and Name status set to approved 70586 APPROVED